Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sinarmas Multiartha Tbk. (SMMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Sinarmas Multiartha Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sinarmas Multiartha Tbk. trades at Rp20,025 (market cap 127.51T, 300 24h volume). The key difference: Sinarmas Multiartha Tbk. is far larger — about 1221.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SMMA | |
|---|---|---|
Market Cap | 104.4B | 127.51T |
Volume | — | 300 |
Lot | — | 3 |
Turnover | — | 6M |
Average Price | — | 20,008.33 |
Value | — | 6M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Sinarmas Multiartha Tbk.
PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Read more on SMMA →
